Phibro(US:PAHC) ZACKS·2025-05-21 17:06Company Overview - Phibro Animal Health (PAHC) currently has a Momentum Style Score of B, indicating a positive momentum outlook [2] - The company is rated 2 (Buy) by the Zacks Rank, which has a strong track record of outperforming the market [3] Momentum Indicators - PAHC shares have increased by 6.81% over the past week, outperforming the Zacks Medical - Products industry, which rose by 2.46% during the same period [5] - Over the last month, PAHC's stock price has changed by 41.37%, significantly higher than the industry's 3.6% performance [5] - In the last quarter, PAHC shares increased by 9%, and over the past year, they gained 31.14%, while the S&P 500 saw movements of -2.63% and 13.25%, respectively [6] Trading Volume - The average 20-day trading volume for PAHC is 258,588 shares, which serves as a baseline for price-to-volume analysis [7] Earnings Outlook - In the past two months, four earnings estimates for PAHC have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $1.94 to $2.01 [9] - For the next fiscal year, four estimates have also moved upwards without any downward revisions [9] Conclusion - Considering the positive momentum indicators and earnings outlook, PAHC is positioned as a promising investment opportunity with a Momentum Score of B [11]